Feng Lou

1.1k total citations
40 papers, 529 citations indexed

About

Feng Lou is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Feng Lou has authored 40 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cancer Research, 19 papers in Pulmonary and Respiratory Medicine and 13 papers in Oncology. Recurrent topics in Feng Lou's work include Cancer Genomics and Diagnostics (22 papers), Lung Cancer Treatments and Mutations (11 papers) and Genetic factors in colorectal cancer (9 papers). Feng Lou is often cited by papers focused on Cancer Genomics and Diagnostics (22 papers), Lung Cancer Treatments and Mutations (11 papers) and Genetic factors in colorectal cancer (9 papers). Feng Lou collaborates with scholars based in China, United States and United Kingdom. Feng Lou's co-authors include Wei Chen, Mingyu Zhao, Lindsey Jones, Xue F. Huang, Hua Ye, Rong Shi, Kezhong Chen, Fan Yang, Si–Yi Chen and Shanbo Cao and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Scientific Reports.

In The Last Decade

Feng Lou

35 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feng Lou China 10 334 324 186 161 97 40 529
Cécile Jovelet France 11 246 0.7× 222 0.7× 200 1.1× 136 0.8× 56 0.6× 31 416
Laure Sorber Belgium 10 420 1.3× 211 0.7× 172 0.9× 291 1.8× 82 0.8× 15 543
Roberta Sgariglia Italy 14 341 1.0× 318 1.0× 317 1.7× 225 1.4× 160 1.6× 29 686
Chuanhua Zhao China 12 133 0.4× 141 0.4× 278 1.5× 80 0.5× 93 1.0× 35 420
Mariantonia Nacchio Italy 12 207 0.6× 232 0.7× 183 1.0× 137 0.9× 64 0.7× 31 433
Clara Mayo‐de‐las‐Casas Spain 9 308 0.9× 337 1.0× 236 1.3× 215 1.3× 51 0.5× 14 558
Xinqing Lin China 14 74 0.2× 282 0.9× 421 2.3× 113 0.7× 79 0.8× 65 585
Clarence Eng United States 8 158 0.5× 79 0.2× 130 0.7× 131 0.8× 55 0.6× 16 342
Sabine Weickmann Germany 13 460 1.4× 205 0.6× 129 0.7× 568 3.5× 55 0.6× 17 749
Marco Mora Italy 10 99 0.3× 153 0.5× 226 1.2× 95 0.6× 46 0.5× 19 571

Countries citing papers authored by Feng Lou

Since Specialization
Citations

This map shows the geographic impact of Feng Lou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Lou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Lou more than expected).

Fields of papers citing papers by Feng Lou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Lou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Lou. The network helps show where Feng Lou may publish in the future.

Co-authorship network of co-authors of Feng Lou

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Lou. A scholar is included among the top collaborators of Feng Lou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Lou. Feng Lou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Diying, Lixia Liu, Xiaojun Xu, et al.. (2023). Spectrum and clinical features of gene mutations in Chinese pediatric acute lymphoblastic leukemia. BMC Pediatrics. 23(1). 62–62. 2 indexed citations
2.
Chen, Junru, Guangxi Sun, Junjie Zhao, et al.. (2023). The mutational pattern of homologous recombination repair genes in urothelial carcinoma and its correlation with immunotherapeutic response. Cancer Medicine. 12(24). 22370–22380. 5 indexed citations
3.
Liu, Weifeng, Huanqing Cheng, Zhen Huang, et al.. (2023). The correlation between clinical outcomes and genomic analysis with high risk factors for the progression of osteosarcoma. Molecular Oncology. 18(4). 939–955. 4 indexed citations
5.
Li, Hongsen, Huanqing Cheng, Huina Wang, et al.. (2022). Comprehensive Molecular Profiling of Colorectal Cancer With Situs Inversus Totalis by Next-Generation Sequencing. Frontiers in Oncology. 12. 813253–813253.
6.
Yang, Min, Jinghan Wang, Yi Zhang, et al.. (2022). A Predictor Combining Clinical and Genetic Factors for AML1-ETO Leukemia Patients. Frontiers in Oncology. 11. 783114–783114. 6 indexed citations
7.
Kong, Wen, Tongtong Yang, Xiaodong Wen, et al.. (2021). Germline Mutation Landscape and Associated Clinical Characteristics in Chinese Patients With Renal Cell Carcinoma. Frontiers in Oncology. 11. 737547–737547. 13 indexed citations
8.
Zeng, Chun, Jing Wang, Mingwei Li, et al.. (2021). Comprehensive Molecular Characterization of Chinese Patients with Glioma by Extensive Next-Generation Sequencing Panel Analysis. Cancer Management and Research. Volume 13. 3573–3588. 8 indexed citations
9.
Zhou, Tao, Libin Chen, Mengmeng Zhang, et al.. (2021). MSIFinder: a python package for detecting MSI status using random forest classifier. BMC Bioinformatics. 22(1). 185–185. 9 indexed citations
10.
Pan, Hongming, Huanqing Cheng, Huina Wang, et al.. (2021). Molecular profiling and identification of prognostic factors in Chinese patients with small bowel adenocarcinoma. Cancer Science. 112(11). 4758–4771. 8 indexed citations
11.
Zhao, Tuanjie, Zhiliang Zhang, Huanhuan Liu, et al.. (2021). Landscape of homologous recombination-related (HRR) genes mutations in colon cancer.. Journal of Clinical Oncology. 39(15_suppl). e15525–e15525. 2 indexed citations
12.
Yang, Kaiwei, Wei Yu, Huanhuan Liu, et al.. (2021). Comparison of Genomic Characterization in Upper Tract Urothelial Carcinoma and Urothelial Carcinoma of the Bladder. The Oncologist. 26(8). e1395–e1405. 30 indexed citations
13.
Ruan, Min, Lipeng Liu, Ben-Quan Qi, et al.. (2021). Targeted Next-Generation Sequencing of Circulating Tumor DNA, Bone Marrow, and Peripheral Blood Mononuclear Cells in Pediatric AML. Frontiers in Oncology. 11. 666470–666470. 10 indexed citations
14.
Chen, Kezhong, Jingbo Zhang, Fan Yang, et al.. (2017). Comparison of plasma to tissue DNA mutations in surgical patients with non–small cell lung cancer. Journal of Thoracic and Cardiovascular Surgery. 154(3). 1123–1131.e2. 42 indexed citations
15.
Chen, Kezhong, Jingbo Zhang, Wei Chen, et al.. (2017). MA17.03 Identifying Genomic Alteration and Inter-Tumor Heterogeneity of Multiple Primary Lung Cancers by Targeted NGS of Tumor Tissue and ctDNA. Journal of Thoracic Oncology. 12(1). S442–S443. 1 indexed citations
16.
Chen, Kezhong, Wei Chen, Fan Yang, et al.. (2017). Favorable prognosis and high discrepancy of genetic features in surgical patients with multiple primary lung cancers. Journal of Thoracic and Cardiovascular Surgery. 155(1). 371–379.e1. 45 indexed citations
17.
Guo, Nannan, Feng Lou, Yongfu Ma, et al.. (2016). Circulating tumor DNA detection in lung cancer patients before and after surgery. Scientific Reports. 6(1). 33519–33519. 92 indexed citations
18.
Chen, Kezhong, Feng Lou, Fan Yang, et al.. (2016). Circulating Tumor DNA Detection in Early-Stage Non-Small Cell Lung Cancer Patients by Targeted Sequencing. Scientific Reports. 6(1). 31985–31985. 101 indexed citations
19.
Xu, Song, Feng Lou, Daqiang Sun, et al.. (2015). Circulating tumor DNA identified by targeted sequencing in advanced-stage non-small cell lung cancer patients. Cancer Letters. 370(2). 324–331. 85 indexed citations
20.
Bai, Jun, Jianhua Wang, Jianhui Li, et al.. (2015). Genetic mutations in human rectal cancers detected by targeted sequencing. Journal of Human Genetics. 60(10). 589–596. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026